熱門資訊> 正文
Purple Biotech GAAP EPADS为-0.57美元
2025-08-06 19:44
- Purple Biotech(PPBT) 0
- Cambria Global Asset Allocation ETF(GAA) 0
- Empire Petroleum Corporation Common Stock(EP) 0
- Purple Biotech press release (NASDAQ:PPBT): Q2 GAAP EPADS of -$0.57.
- As of June 30, 2025, Purple Biotech had cash and cash equivalents and short-term deposits of $5.6 million. The Company cash runway is expected into the third quarter of 2026.
More on Purple Biotech
- Seeking Alpha’s Quant Rating on Purple Biotech
- Historical earnings data for Purple Biotech
- Financial information for Purple Biotech
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
